Data updated: Mar 10, 2026
CARBON DIOXIDE, USP
CARBON DIOXIDE X-Ray Contrast Activity
Approved 2013-07-05
18
Indications
--
Phase 3 Trials
12
Years on Market
Details
- Status
- Prescription
- First Approved
- 2013-07-05
- Routes
- INHALATION
- Dosage Forms
- GAS
Companies
PRAXAIR INC RELIANT HOLDINGS LTD A-OX WELDING SUPPLY CO, INC. MIDDLESEX GASES TECHNOLOGIES, INC. NEXAIR LLC MITCHELL WEDLING SUPPLY LINDE MERCHANT PRODUCTIONS INC CENTRAL WELDING SUPPLY DJB GAS SERVICES, INC ROBERTS OXYGEN CO INC AIRGAS CARBONIC INC LINDE GAS EQUIP AIRGAS USA LLC LISS AMERICA LLC CONTINENTAL CARBONIC PRODUCTS, INC. HAUN SPECIALTY GASES INC LINDE NORTH AMERICA INC WELDERS SUPPLY COMPANY OF LOUISVILLE INC GENERAL DISTRIBUTING COMPANY
Active Ingredient: CARBON DIOXIDE
Website: ↗
CARBON DIOXIDE, USP Approval History
Loading approval history...
What CARBON DIOXIDE, USP Treats
18 FDA approvalsOriginally approved for its first indication in 2013 . Covers 18 distinct patient populations.
- Other (18)
Other
(18 approvals)- • Approved indication (Jul 2013)Letter
- • Approved indication (Jul 2013)Letter
- • Approved indication (Jul 2013)Letter
- • Approved indication (Sep 2013)Letter
- • Approved indication (May 2014)Letter
- • Approved indication (Aug 2017)
- • Approved indication (Jun 2019)Letter
- • Approved indication (Jul 2020)Letter
- • Approved indication (Oct 2021)Letter
- • Approved indication (Feb 2022)Letter
- • Approved indication (Apr 2022)Letter
- • Approved indication (Feb 2024)Letter
- • Approved indication (Aug 2024)Letter
- • Approved indication (Nov 2024)Letter
- • Approved indication (Feb 2025)Letter
- • Approved indication (Apr 2025) NewLetter
- • Approved indication (Jun 2025) NewLetter
- • Approved indication (Oct 2025) NewLetter
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CARBON DIOXIDE, USP FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.